Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains.
Singh A, Mitra M, Sampath G, Venugopal P, Rao JV, Krishnamurthy B, Gupta MK, Sri Krishna S, Sudhakar B, Rao NB, Kaushik Y, Gopinathan K, Hegde NR, Gore MM, Krishna Mohan V, Ella KM. Singh A, et al. Among authors: sampath g. J Infect Dis. 2015 Sep 1;212(5):715-25. doi: 10.1093/infdis/jiv023. Epub 2015 Jan 18. J Infect Dis. 2015. PMID: 25601942 Clinical Trial.
Evaluation of safety and immunogenicity of HNVAC, an MDCK-based H1N1 pandemic influenza vaccine, in Phase I single centre and Phase II/III multi-centre, double-blind, randomized, placebo-controlled, parallel assignment studies.
Basavaraj VH, Sampath G, Hegde NR, Mohan VK, Ella KM. Basavaraj VH, et al. Among authors: sampath g. Vaccine. 2014 Jul 31;32(35):4592-4597. doi: 10.1016/j.vaccine.2014.05.039. Epub 2014 May 21. Vaccine. 2014. PMID: 24856782 Clinical Trial.
Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study.
Sampath G, Banzhoff A, Deshpande A, Malerczyk C, Arora AK, Vakil H, Preiss S. Sampath G, et al. Hum Vaccin Immunother. 2017 Jul 3;13(7):1531-1538. doi: 10.1080/21645515.2017.1307483. Epub 2017 Apr 13. Hum Vaccin Immunother. 2017. PMID: 28406752 Free PMC article. Clinical Trial.
Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman-Moore strain) manufactured in India.
Ashwath Narayana DH, Madhusudana SN, Sampath G, Tripathy RM, Sudarshan MK, Gangaboraiah, Ravish HS, Satapathy DM, Gowda G, Holla R, Ashwin BY, Padhi A, Manjula S, Patel PM. Ashwath Narayana DH, et al. Among authors: sampath g. Hum Vaccin Immunother. 2014;10(1):120-5. doi: 10.4161/hv.26456. Epub 2013 Sep 12. Hum Vaccin Immunother. 2014. PMID: 24030586 Free PMC article. Clinical Trial.
A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).
Ashwathnarayana DH, Madhusudana SN, Sampath G, Sathpathy DM, Mankeshwar R, Ravish HH, Ullas PT, Behra TR, Sudarshan MK, Gangaboraiah, Shamanna M. Ashwathnarayana DH, et al. Among authors: sampath g. Vaccine. 2009 Dec 10;28(1):148-51. doi: 10.1016/j.vaccine.2009.09.090. Epub 2009 Oct 8. Vaccine. 2009. PMID: 19818720 Clinical Trial.
A comparative study on the immunogenicity, safety and tolerance of purified duck embryo vaccine (PDEV) manufactured in India (Vaxirab) and Switzerland (Lyssavac-N): a randomized simulated post-exposure study in healthy volunteers.
Mahendra BJ, Madhusudana SN, Ashwathnarayana DH, Sampath G, datta SS, Sudarshan MK, Venkatesh GM, Muhamuda K, Bilagumba G, Shamanna M. Mahendra BJ, et al. Among authors: sampath g. Vaccine. 2007 Dec 5;25(50):8405-9. doi: 10.1016/j.vaccine.2007.10.002. Epub 2007 Oct 22. Vaccine. 2007. PMID: 17981377 Clinical Trial.
42 results